NM_018062.4(FANCL):c.1_22dup (p.Leu8fs) AND Fanconi anemia complementation group L

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Sep 1, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002283914.1

Allele description [Variation Report for NM_018062.4(FANCL):c.1_22dup (p.Leu8fs)]

NM_018062.4(FANCL):c.1_22dup (p.Leu8fs)

Gene:

FANCL:FA complementation group L [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

2p16.1

Genomic location:

Preferred name:

NM_018062.4(FANCL):c.1_22dup (p.Leu8fs)

HGVS:

NC_000002.12:g.58241298_58241319dup
NG_007418.1:g.5067_5088dup
NM_001114636.2:c.-6_16dup
NM_001374615.1:c.1_22dup
NM_001410792.1:c.1_22dup
NM_018062.4:c.1_22dupMANE SELECT
NP_001108108.1:p.Leu8fs
NP_001108108.1:p.Met(?_1)_Ala6(?)
NP_001361544.1:p.Leu8fs
NP_001397721.1:p.Leu8fs
NP_060532.2:p.Leu8fs
NP_060532.2:p.Met(?_1)_Ala6(?)
LRG_501t1:c.1_22dup
LRG_501t2:c.-6_16dup
LRG_501:g.5067_5088dup
LRG_501p1:p.Leu8fs
LRG_501p2:p.Met(?_1)_Ala6(?)
NC_000002.11:g.58468433_58468454dup
NM_001114636.1:c.1_22dup
NM_018062.3:c.-6_16dup
NR_156742.1:n.68_89dup
NR_156742.2:n.7_28dup
NR_164659.2:n.7_28dup

Protein change:

L8fs

Molecular consequence:

NM_001114636.2:c.-6_16dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001374615.1:c.1_22dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001410792.1:c.1_22dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_018062.4:c.1_22dup - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001374615.1:c.1_22dup - initiator_codon_variant - [Sequence Ontology: SO:0001582]
NM_001410792.1:c.1_22dup - initiator_codon_variant - [Sequence Ontology: SO:0001582]
NM_018062.4:c.1_22dup - initiator_codon_variant - [Sequence Ontology: SO:0001582]

Observations:

Condition(s)

Name:: Fanconi anemia complementation group L (FANCL)
Identifiers:: MONDO: MONDO:0013566; MedGen: C3469528; Orphanet: 84; OMIM: 614083

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002573113	3billion	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely pathogenic (Sep 1, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002573113

3billion

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely pathogenic
(Sep 1, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	1	not provided	not provided	1	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From 3billion, SCV002573113.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. It is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	1	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Dec 30, 2023

ClinVar

Relating variation to medicine